7/30/2013 12:40:37 PM - Perched near its 52-week high today holding its ground following a considerable "breakaway gap" with heavy volume on 7/26/13. This Italy-based Medical - Biomed/Biotech firm with minuscule but increasing sales revenues growth has survived but failed to impress since last noted with caution in the 3/24/11 mid-day report - "Recent quarterly comparisons show sales and earnings improving after a long history of losses. Low priced stocks are discouraged under the investment system guidelines."
3/24/2011 12:12:34 PM - Up today for another new 52-week high, but well off its early session highs. The 3 prior mid-day reports noted - "Gain today for a new 52-week high. This Italy-based Medical - Biomed/Biotech firm with minuscule but increasing sales revenues growth found support at its 50 DMA line during its consolidation since last noted in the 2/09/11 mid-day report - 'Recent quarterly comparisons show sales and earnings improving after a long history of losses. Low priced stocks are discouraged under the investment system guidelines.'"
3/23/2011 12:22:39 PM - Up today for another new 52-week high. The 2 prior mid-day reports noted - "Gain today for a new 52-week high. This Italy-based Medical - Biomed/Biotech firm with minuscule but increasing sales revenues growth found support at its 50 DMA line during its consolidation since last noted in the 2/09/11 mid-day report - 'Recent quarterly comparisons show sales and earnings improving after a long history of losses. Low priced stocks are discouraged under the investment system guidelines.'"
3/22/2011 12:28:05 PM - Gapped up today for a new high. The 3/21/11 mid-day report noted - "Gain today for a new 52-week high. This Italy-based Medical - Biomed/Biotech firm with minuscule but increasing sales revenues growth found support at its 50 DMA line during its consolidation since last noted in the 2/09/11 mid-day report - 'Recent quarterly comparisons show sales and earnings improving after a long history of losses. Low priced stocks are discouraged under the investment system guidelines.'"
3/21/2011 12:07:01 PM - Gain today for a new 52-week high. This Italy-based Medical - Biomed/Biotech firm with minuscule but increasing sales revenues growth found support at its 50 DMA line during its consolidation since last noted in the 2/09/11 mid-day report - "Recent quarterly comparisons show sales and earnings improving after a long history of losses. Low priced stocks are discouraged under the investment system guidelines."
2/9/2011 12:37:44 PM - Gapped up and hit a new 52-week high today with a 7th consecutive small gain. Held its ground stubbornly after it gapped up on 1/11/11 when the mid-day report noted it - "Breaking out from a cup-with-handle type pattern. Recent quarterly comparisons show sales and earnings improving after a long history of losses. Low priced stocks are discouraged under the investment system guidelines."
2/8/2011 1:26:32 PM - Consolidating near its 52-week high. Held its ground stubbornly after it gapped up on 1/11/11 when the mid-day report noted it - "Breaking out from a cup-with-handle type pattern. Recent quarterly comparisons show sales and earnings improving after a long history of losses. Low priced stocks are discouraged under the investment system guidelines."
1/19/2011 12:41:05 PM - Gapped up today for another new 52-week high. Held its ground stubbornly after it gapped up on 1/11/11 when the mid-day report noted it - "Breaking out from a cup-with-handle type pattern. Recent quarterly comparisons show sales and earnings improving after a long history of losses. Low priced stocks are discouraged under the investment system guidelines."
1/11/2011 1:44:09 PM - Gapped up today for a new 52-week high, breaking ouf from a cup-with-handle type pattern. Recent quarterly comparisons show sales and earnings improving after a long history of losses. Low priced stocks are discouraged under the investment system guidelines.